Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global CAR T-Cell Immunotherapy Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global CAR T-Cell Immunotherapy Market Status and Forecast (2016-2027)
      • 1.3.2 Global CAR T-Cell Immunotherapy Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global CAR T-Cell Immunotherapy Supply by Company

    • 2.1 Global CAR T-Cell Immunotherapy Sales Value by Company
    • 2.2 CAR T-Cell Immunotherapy Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional CAR T-Cell Immunotherapy Market Status by Category

    • 3.1 CAR T-Cell Immunotherapy Category Introduction
      • 3.1.1 Monotherapy
      • 3.1.2 Combination Therapy
    • 3.2 Global CAR T-Cell Immunotherapy Market by Category
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional CAR T-Cell Immunotherapy Market Status by End User/Segment

    • 4.1 CAR T-Cell Immunotherapy Segment by End User/Segment
      • 4.1.1 Hematologic Malignancies
      • 4.1.2 Solid Malignancies
    • 4.2 Global CAR T-Cell Immunotherapy Market by End User/Segment
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global CAR T-Cell Immunotherapy Market Status by Region

    • 5.1 Global CAR T-Cell Immunotherapy Market by Region
    • 5.2 North America CAR T-Cell Immunotherapy Market Status
    • 5.3 Europe CAR T-Cell Immunotherapy Market Status
    • 5.4 Asia Pacific CAR T-Cell Immunotherapy Market Status
    • 5.5 Central & South America CAR T-Cell Immunotherapy Market Status
    • 5.6 Middle East & Africa CAR T-Cell Immunotherapy Market Status

    6 North America CAR T-Cell Immunotherapy Market Status

    • 6.1 North America CAR T-Cell Immunotherapy Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe CAR T-Cell Immunotherapy Market Status

    • 7.1 Europe CAR T-Cell Immunotherapy Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific CAR T-Cell Immunotherapy Market Status

    • 8.1 Asia Pacific CAR T-Cell Immunotherapy Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America CAR T-Cell Immunotherapy Market Status

    • 9.1 Central & South America CAR T-Cell Immunotherapy Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa CAR T-Cell Immunotherapy Market Status

    • 10.1 Middle East & Africa CAR T-Cell Immunotherapy Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global CAR T-Cell Immunotherapy Market Forecast by Category and by End User/Segment

    • 12.1 Global CAR T-Cell Immunotherapy Sales Value Forecast (2022-2027)
    • 12.2 Global CAR T-Cell Immunotherapy Forecast by Category
    • 12.3 Global CAR T-Cell Immunotherapy Forecast by End User/Segment

    13 Global CAR T-Cell Immunotherapy Market Forecast by Region/Country

    • 13.1 Global CAR T-Cell Immunotherapy Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Ziopharm Oncology
      • 14.1.1 Company Information
      • 14.1.2 CAR T-Cell Immunotherapy Product Introduction
      • 14.1.3 Ziopharm Oncology CAR T-Cell Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Xyphos
      • 14.2.1 Company Information
      • 14.2.2 CAR T-Cell Immunotherapy Product Introduction
      • 14.2.3 Xyphos CAR T-Cell Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Pfizer
      • 14.3.1 Company Information
      • 14.3.2 CAR T-Cell Immunotherapy Product Introduction
      • 14.3.3 Pfizer CAR T-Cell Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Oxford BioMedica
      • 14.4.1 Company Information
      • 14.4.2 CAR T-Cell Immunotherapy Product Introduction
      • 14.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Novartis
      • 14.5.1 Company Information
      • 14.5.2 CAR T-Cell Immunotherapy Product Introduction
      • 14.5.3 Novartis CAR T-Cell Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Mustang Bio
      • 14.6.1 Company Information
      • 14.6.2 CAR T-Cell Immunotherapy Product Introduction
      • 14.6.3 Mustang Bio CAR T-Cell Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Minerva Biotechnologies
      • 14.7.1 Company Information
      • 14.7.2 CAR T-Cell Immunotherapy Product Introduction
      • 14.7.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Kite Pharma
      • 14.8.1 Company Information
      • 14.8.2 CAR T-Cell Immunotherapy Product Introduction
      • 14.8.3 Kite Pharma CAR T-Cell Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Gilead
      • 14.9.1 Company Information
      • 14.9.2 CAR T-Cell Immunotherapy Product Introduction
      • 14.9.3 Gilead CAR T-Cell Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Creative Biolabs
      • 14.10.1 Company Information
      • 14.10.2 CAR T-Cell Immunotherapy Product Introduction
      • 14.10.3 Creative Biolabs CAR T-Cell Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 Cellectis
    • 14.12 Celgene
    • 14.13 CARsgen Therapeutics
    • 14.14 Bellicum
    • 14.15 Aurora Biopharma
    • 14.16 Adaptimmune
    • 14.17 AbbVie

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global CAR T-Cell Immunotherapy market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global CAR T-Cell Immunotherapy market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Monotherapy
      Combination Therapy

      Segmented by End User/Segment
      Hematologic Malignancies
      Solid Malignancies

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Ziopharm Oncology
      Xyphos
      Pfizer
      Oxford BioMedica
      Novartis
      Mustang Bio
      Minerva Biotechnologies
      Kite Pharma
      Gilead
      Creative Biolabs
      Cellectis
      Celgene
      CARsgen Therapeutics
      Bellicum
      Aurora Biopharma
      Adaptimmune
      AbbVie
      Buy now